Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

The Biology Behind

  • The Biology Behind
    Rexinoids and Breast Cancer Prevention
    Louise R. Howe
    Clin Cancer Res October 15 2007 13 (20) 5983-5987; DOI:10.1158/1078-0432.CCR-07-1065

The Clinical Connection

  • The Clinical Connection
    Phosphatidylinositol 3-Kinase in Breast Cancer: Where from Here?
    Paradiso Angelo, Mangia Anita, Azzariti Amalia and Tommasi Stefania
    Clin Cancer Res October 15 2007 13 (20) 5988-5990; DOI:10.1158/1078-0432.CCR-07-1106

Molecular Pathways

  • Molecular Pathways
    The Universal Character of the Tumor-Associated Antigen Survivin
    Mads Hald Andersen, Inge Marie Svane, Jürgen C. Becker and Per thor Straten
    Clin Cancer Res October 15 2007 13 (20) 5991-5994; DOI:10.1158/1078-0432.CCR-07-0686

  • Molecular Pathways
    The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer
    Domagoj Vucic and Wayne J. Fairbrother
    Clin Cancer Res October 15 2007 13 (20) 5995-6000; DOI:10.1158/1078-0432.CCR-07-0729

Human Cancer Biology

  • Human Cancer Biology
    De novo Identification of MIZ-1 (ZBTB17) Encoding a MYC-Interacting Zinc-Finger Protein as a New Favorable Neuroblastoma Gene
    Naohiko Ikegaki, Takahiro Gotoh, Bing Kung, Justin S. Riceberg, David Y. Kim, Huaqing Zhao, Eric F. Rappaport, Sakeenah L. Hicks, Robert C. Seeger and Xao X. Tang
    Clin Cancer Res October 15 2007 13 (20) 6001-6009; DOI:10.1158/1078-0432.CCR-07-0071

  • Human Cancer Biology
    Canonical Nuclear Factor κB Pathway Inhibition Blocks Myeloma Cell Growth and Induces Apoptosis in Strong Synergy with TRAIL
    Mathilde Romagnoli, Grégoire Desplanques, Sophie Maïga, Steven Legouill, Michel Dreano, Régis Bataille and Sophie Barillé-Nion
    Clin Cancer Res October 15 2007 13 (20) 6010-6018; DOI:10.1158/1078-0432.CCR-07-0140

  • Human Cancer Biology
    Genome-Wide Allelotypes of Familial Pancreatic Adenocarcinomas and Familial and Sporadic Intraductal Papillary Mucinous Neoplasms
    Tadayoshi Abe, Noriyoshi Fukushima, Kieran Brune, Corinne Boehm, Norihiro Sato, Hiroyuki Matsubayashi, Marcia Canto, Gloria M. Petersen, Ralph H. Hruban and Michael Goggins
    Clin Cancer Res October 15 2007 13 (20) 6019-6025; DOI:10.1158/1078-0432.CCR-07-0471

  • Human Cancer Biology
    Hyperdiploidy Is a Common Finding in Monoclonal Gammopathy of Undetermined Significance and Monosomy 13 Is Restricted to These Hyperdiploid Patients
    Maud Brousseau, Xavier Leleu, Jérémie Gerard, Thomas Gastinne, Alban Godon, Franck Genevieve, Mamoun Dib, Jean-Luc Lai, Thierry Facon and Marc Zandecki
    Clin Cancer Res October 15 2007 13 (20) 6026-6031; DOI:10.1158/1078-0432.CCR-07-0031

  • Human Cancer Biology
    The Double-Stranded RNA-Activated Protein Kinase Mediates Radiation Resistance in Mouse Embryo Fibroblasts through Nuclear Factor κB and Akt Activation
    Urs von Holzen, Abujiang Pataer, Uma Raju, Dora Bocangel, Stephan A. Vorburger, Yanna Liu, Xiaolin Lu, Jack A. Roth, Bharat B. Aggarwal, Glen N. Barber, Khandan Keyomarsi, Kelly K. Hunt and Stephen G. Swisher
    Clin Cancer Res October 15 2007 13 (20) 6032-6039; DOI:10.1158/1078-0432.CCR-06-2932

  • Human Cancer Biology
    PrLZ Is Expressed in Normal Prostate Development and in Human Prostate Cancer Progression
    Ruoxiang Wang, Jianchun Xu, Nicola Mabjeesh, Guodong Zhu, Jianguang Zhou, Mahul Amin, Dalin He, Fray F. Marshall, Haiyen E. Zhau and Leland W.K. Chung
    Clin Cancer Res October 15 2007 13 (20) 6040-6048; DOI:10.1158/1078-0432.CCR-07-0640

  • Human Cancer Biology
    Identification of a Met-Binding Peptide from a Phage Display Library
    Ping Zhao, Tessa Grabinski, Chongfeng Gao, R. Scot Skinner, Troy Giambernardi, Yanli Su, Eric Hudson, James Resau, Milton Gross, George F. Vande Woude, Rick Hay and Brian Cao
    Clin Cancer Res October 15 2007 13 (20) 6049-6055; DOI:10.1158/1078-0432.CCR-07-0035

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Expression of X-Linked Inhibitor of Apoptosis Protein Is a Strong Predictor of Human Prostate Cancer Recurrence
    David B. Seligson, Fumiya Hongo, Sara Huerta-Yepez, Yoichi Mizutani, Tsuneharu Miki, Hong Yu, Steve Horvath, David Chia, Lee Goodglick and Benjamin Bonavida
    Clin Cancer Res October 15 2007 13 (20) 6056-6063; DOI:10.1158/1078-0432.CCR-07-0960

  • Imaging, Diagnosis, Prognosis
    Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the PIK3CA Gene in Breast Carcinomas
    Mattia Barbareschi, Fiamma Buttitta, Lara Felicioni, Sabrina Cotrupi, Fabio Barassi, Maela Del Grammastro, Antonella Ferro, Paolo Dalla Palma, Enzo Galligioni and Antonio Marchetti
    Clin Cancer Res October 15 2007 13 (20) 6064-6069; DOI:10.1158/1078-0432.CCR-07-0266

  • Imaging, Diagnosis, Prognosis
    Evaluation of an 111In-Radiolabeled Peptide as a Targeting and Imaging Agent for ErbB-2 Receptor–Expressing Breast Carcinomas
    Senthil R. Kumar, Thomas P. Quinn and Susan L. Deutscher
    Clin Cancer Res October 15 2007 13 (20) 6070-6079; DOI:10.1158/1078-0432.CCR-07-0160

  • Imaging, Diagnosis, Prognosis
    Pharmacogenomic Predictor Discovery in Phase II Clinical Trials for Breast Cancer
    Lajos Pusztai, Keith Anderson and Kenneth R. Hess
    Clin Cancer Res October 15 2007 13 (20) 6080-6086; DOI:10.1158/1078-0432.CCR-07-0809

  • Imaging, Diagnosis, Prognosis
    Synchronous Alterations of Wnt and Epidermal Growth Factor Receptor Signaling Pathways through Aberrant Methylation and Mutation in Non–Small Cell Lung Cancer
    Makoto Suzuki, Hisayuki Shigematsu, Takahiro Nakajima, Rieko Kubo, Shinichiro Motohashi, Yasuo Sekine, Kiyoshi Shibuya, Toshihiko Iizasa, Kenzo Hiroshima, Yukio Nakatani, Adi F. Gazdar and Takehiko Fujisawa
    Clin Cancer Res October 15 2007 13 (20) 6087-6092; DOI:10.1158/1078-0432.CCR-07-0591

  • Imaging, Diagnosis, Prognosis
    Association between DNA Methylation and Shortened Survival in Patients with Advanced Colorectal Cancer Treated with 5-Fluorouracil–Based Chemotherapy
    Lanlan Shen, Paul J. Catalano, Al B. Benson III, Peter O'Dwyer, Stanley R. Hamilton and Jean-Pierre J. Issa
    Clin Cancer Res October 15 2007 13 (20) 6093-6098; DOI:10.1158/1078-0432.CCR-07-1011

  • Imaging, Diagnosis, Prognosis
    p53 Mutations in Deep Tissues Are More Strongly Associated with Recurrence than Mutation-Positive Mucosal Margins
    Xiaohong Huang, Stelios Pateromichelakis, Allison Hills, Martyn Sherriff, Andrew Lyons, John Langdon, Edward Odell, Peter Morgan, John Harrison and Max Partridge
    Clin Cancer Res October 15 2007 13 (20) 6099-6106; DOI:10.1158/1078-0432.CCR-07-1369

  • Imaging, Diagnosis, Prognosis
    High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease
    Stefanie Sarantopoulos, Kristen E. Stevenson, Haesook T. Kim, Nazmim S. Bhuiya, Corey S. Cutler, Robert J. Soiffer, Joseph H. Antin and Jerome Ritz
    Clin Cancer Res October 15 2007 13 (20) 6107-6114; DOI:10.1158/1078-0432.CCR-07-1290

  • Imaging, Diagnosis, Prognosis
    Wwox and Ap2γ Expression Levels Predict Tamoxifen Response
    Gulnur Guler, Dimitrios Iliopoulos, Nilufer Guler, Cigdem Himmetoglu, Mutlu Hayran and Kay Huebner
    Clin Cancer Res October 15 2007 13 (20) 6115-6121; DOI:10.1158/1078-0432.CCR-07-1282

  • Imaging, Diagnosis, Prognosis
    High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer Patients
    Rui Henrique, Franclim R. Ribeiro, Daniel Fonseca, Mohammad O. Hoque, André L. Carvalho, Vera L. Costa, Mafalda Pinto, Jorge Oliveira, Manuel R. Teixeira, David Sidransky and Carmen Jerónimo
    Clin Cancer Res October 15 2007 13 (20) 6122-6129; DOI:10.1158/1078-0432.CCR-07-1042

  • Imaging, Diagnosis, Prognosis
    Enhancing Fraction Predicts Clinical Outcome following First-Line Chemotherapy in Patients with Epithelial Ovarian Carcinoma
    James P.B. O'Connor, Gordon C. Jayson, Alan Jackson, Dana Ghiorghiu, Bernadette M. Carrington, Chris J. Rose, Samantha J. Mills, Ric Swindell, Caleb Roberts, Claire L. Mitchell and Geoffrey J.M. Parker
    Clin Cancer Res October 15 2007 13 (20) 6130-6135; DOI:10.1158/1078-0432.CCR-07-0331

  • Imaging, Diagnosis, Prognosis
    A Half-Log Increase in BCR-ABL RNA Predicts a Higher Risk of Relapse in Patients with Chronic Myeloid Leukemia with an Imatinib-Induced Complete Cytogenetic Response
    Richard D. Press, Chad Galderisi, Rui Yang, Carole Rempfer, Stephanie G. Willis, Michael J. Mauro, Brian J. Druker and Michael W.N. Deininger
    Clin Cancer Res October 15 2007 13 (20) 6136-6143; DOI:10.1158/1078-0432.CCR-07-1112

  • Imaging, Diagnosis, Prognosis
    Magnetic Resonance Imaging of the Breast Improves Detection of Invasive Cancer, Preinvasive Cancer, and Premalignant Lesions during Surveillance of Women at High Risk for Breast Cancer
    Christopher C. Riedl, Lothar Ponhold, Daniel Flöry, Michael Weber, Regina Kroiss, Teresa Wagner, Michael Fuchsjäger and Thomas H. Helbich
    Clin Cancer Res October 15 2007 13 (20) 6144-6152; DOI:10.1158/1078-0432.CCR-07-1270

  • Imaging, Diagnosis, Prognosis
    DNA Replication Licensing Factors and Aurora Kinases are Linked to Aneuploidy and Clinical Outcome in Epithelial Ovarian Carcinoma
    Anjana A. Kulkarni, Marco Loddo, Elisabetta Leo, Mohammed Rashid, Kathryn L. Eward, Thomas R. Fanshawe, Jessica Butcher, Alison Frost, Jonathan A. Ledermann, Gareth H. Williams and Kai Stoeber
    Clin Cancer Res October 15 2007 13 (20) 6153-6161; DOI:10.1158/1078-0432.CCR-07-0671

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Novel Therapy with 2-Methoxyestradiol for the Treatment of Relapsed and Plateau Phase Multiple Myeloma
    S. Vincent Rajkumar, Paul G. Richardson, Martha Q. Lacy, Angela Dispenzieri, Philip R. Greipp, Thomas E. Witzig, Robert Schlossman, Carolyn F. Sidor, Kenneth C. Anderson and Morie A. Gertz
    Clin Cancer Res October 15 2007 13 (20) 6162-6167; DOI:10.1158/1078-0432.CCR-07-0807

  • Cancer Therapy: Clinical
    Phase I Trial of Toll-Like Receptor 9 Agonist PF-3512676 with and Following Rituximab in Patients with Recurrent Indolent and Aggressive Non–Hodgkin's Lymphoma
    John P. Leonard, Brian K. Link, Christos Emmanouilides, Stephanie A. Gregory, Daniel Weisdorf, Jeffrey Andrey, John Hainsworth, Joseph A. Sparano, Donald E. Tsai, Sandra Horning, Arthur M. Krieg and George J. Weiner
    Clin Cancer Res October 15 2007 13 (20) 6168-6174; DOI:10.1158/1078-0432.CCR-07-0815

  • Cancer Therapy: Clinical
    Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer
    Roy S. Herbst, Angela M. Davies, Ronald B. Natale, Thao P. Dang, Joan H. Schiller, Linda L. Garland, Vincent A. Miller, David Mendelson, Annick D. Van den Abbeele, Yulia Melenevsky, Daniel J. de Vries, David A. Eberhard, Benjamin Lyons, Stuart G. Lutzker and Bruce E. Johnson
    Clin Cancer Res October 15 2007 13 (20) 6175-6181; DOI:10.1158/1078-0432.CCR-07-0460

  • Cancer Therapy: Clinical
    A Phase I and Pharmacologic Study of Belotecan in Combination with Cisplatin in Patients with Previously Untreated Extensive-Stage Disease Small Cell Lung Cancer
    Dae Ho Lee, Sang-We Kim, Kyun-Seop Bae, Jeong-Sook Hong, Cheolwon Suh, Yoon-Koo Kang and Jung-Shin Lee
    Clin Cancer Res October 15 2007 13 (20) 6182-6186; DOI:10.1158/1078-0432.CCR-07-0534

  • Cancer Therapy: Clinical
    Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers
    Ruth Plummer, Gerhardt Attard, Simon Pacey, Louise Li, Albiruni Razak, Rebecca Perrett, Mary Barrett, Ian Judson, Stan Kaye, Norma Lynn Fox, Wendy Halpern, Alfred Corey, Hilary Calvert and Johann de Bono
    Clin Cancer Res October 15 2007 13 (20) 6187-6194; DOI:10.1158/1078-0432.CCR-07-0950

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine
    Francesca Orlandi, Franco M. Venanzi, Antonio Concetti, Hanako Yamauchi, Shakuntala Tiwari, Larry Norton, Jedd D. Wolchok, Alan N. Houghton and Polly D. Gregor
    Clin Cancer Res October 15 2007 13 (20) 6195-6203; DOI:10.1158/1078-0432.CCR-07-0258

  • Cancer Therapy: Preclinical
    Combination Treatment of Prostate Cancer Cell Lines with Bioactive Soy Isoflavones and Perifosine Causes Increased Growth Arrest and/or Apoptosis
    Ruth L. Vinall, Kimberley Hwa, Paramita Ghosh, Chong-Xian Pan, Primo N. Lara Jr. and Ralph W. de Vere White
    Clin Cancer Res October 15 2007 13 (20) 6204-6216; DOI:10.1158/1078-0432.CCR-07-0600

  • Cancer Therapy: Preclinical
    Adenovirally Delivered Tumor Necrosis Factor-α Improves the Antiglioma Efficacy of Concomitant Radiation and Temozolomide Therapy
    Bakhtiar Yamini, Xiaohong Yu, Peter Pytel, Nicholas Galanopoulos, Vinay Rawlani, Jula Veerapong, Kai Bickenbach and Ralph R. Weichselbaum
    Clin Cancer Res October 15 2007 13 (20) 6217-6223; DOI:10.1158/1078-0432.CCR-07-1421

Cancer Susceptibility and Prevention

  • Cancer Susceptibility and Prevention
    The Rexinoid LG100268 Prevents the Development of Preinvasive and Invasive Estrogen Receptor–Negative Tumors in MMTV-erbB2 Mice
    Yuxin Li, Yun Zhang, Jamal Hill, Qiang Shen, Hee-Tae Kim, Xiaochun Xu, Susan G. Hilsenbeck, Reid P. Bissonnette, William W. Lamph and Powel H. Brown
    Clin Cancer Res October 15 2007 13 (20) 6224-6231; DOI:10.1158/1078-0432.CCR-06-2681

  • Cancer Susceptibility and Prevention
    Telomere Shortening and Chromosomal Abnormalities in Intestinal Metaplasia of the Urinary Bladder
    Michael J. Morton, Shaobo Zhang, Antonio Lopez-Beltran, Gregory T. MacLennan, John N. Eble, Rodolfo Montironi, Ming-Tse Sung, Puay-Hoon Tan, Suqin Zheng, Honghong Zhou and Liang Cheng
    Clin Cancer Res October 15 2007 13 (20) 6232-6236; DOI:10.1158/1078-0432.CCR-07-0121

  • Cancer Susceptibility and Prevention
    A New Rexinoid, NRX194204, Prevents Carcinogenesis in Both the Lung and Mammary Gland
    Karen Liby, Darlene B. Royce, Renee Risingsong, Charlotte R. Williams, Matthew D. Wood, Roshantha A. Chandraratna and Michael B. Sporn
    Clin Cancer Res October 15 2007 13 (20) 6237-6243; DOI:10.1158/1078-0432.CCR-07-1342

Letter to the Editor

  • Letter to the Editor
    Potential Biomarkers in Metastatic Gastrointestinal Stromal Tumors
    Michiel H. Strijbos, Jaco Kraan, Stefan Sleijfer and Jan W. Gratama
    Clin Cancer Res October 15 2007 13 (20) 6244-6244; DOI:10.1158/1078-0432.CCR-07-1142

Corrections

  • Corrections
    Correction: Article on Pharmacokinetic Study of Vorinostat
    Clin Cancer Res October 15 2007 13 (20) 6245-6245; DOI:10.1158/1078-0432.CCR-13-20-COR1

  • Corrections
    Correction: Article on La Autoantigen
    Clin Cancer Res October 15 2007 13 (20) 6245-6245; DOI:10.1158/1078-0432.CCR-13-20-COR2

Back to top
PreviousNext
Clinical Cancer Research: 13 (20)
October 2007
Volume 13, Issue 20
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Expression of X-Linked Inhibitor of Apoptosis Protein Is a Strong Predictor of Human Prostate Cancer Recurrence
  • Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the PIK3CA Gene in Breast Carcinomas
  • Pharmacogenomic Predictor Discovery in Phase II Clinical Trials for Breast Cancer
  • The Double-Stranded RNA-Activated Protein Kinase Mediates Radiation Resistance in Mouse Embryo Fibroblasts through Nuclear Factor κB and Akt Activation

Jump to

  • The Biology Behind
  • The Clinical Connection
  • Molecular Pathways
  • Human Cancer Biology
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Therapy: Preclinical
  • Cancer Susceptibility and Prevention
  • Letter to the Editor
  • Corrections
Advertisement
  • Most Cited
  • Most Read
Loading
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • FLASH-RT Spares Lung Progenitor Cells
  • AR Gene Rearrangements in Prostate Cancer
  • PDAC and GATA6 Expression
  • Guadecitabine and Carboplatin in Ovarian Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement